Literature DB >> 21493872

Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

Jill S Barnholtz-Sloan1, Xiaowei Guan, Charnita Zeigler-Johnson, Neal J Meropol, Timothy R Rebbeck.   

Abstract

BACKGROUND: Inherited variability in genes that influence androgen metabolism has been associated with risk of prostate cancer. The objective of this analysis was to evaluate interactions for prostate cancer risk by using classification and regression tree (CART) models (i.e., decision trees), and to evaluate whether these interactive effects add information about prostate cancer risk prediction beyond that of "traditional" risk factors.
METHODS: We compared CART models with traditional logistic regression (LR) models for associations of factors with prostate cancer risk using 1,084 prostate cancer cases and 941 controls. All analyses were stratified by race. We used unconditional LR to complement and compare with the race-stratified CART results using the area under curve (AUC) for the receiver operating characteristic curves.
RESULTS: The CART modeling of prostate cancer risk showed different interaction profiles by race. For European Americans, interactions among CYP3A43 genotype, history of benign prostate hypertrophy, family history of prostate cancer, and age at consent revealed a distinct hierarchy of gene-environment and gene-gene interactions, whereas for African Americans, interactions among family history of prostate cancer, individual proportion of European ancestry, number of GGC androgen receptor repeats, and CYP3A4/CYP3A5 haplotype revealed distinct interaction effects from those found in European Americans. For European Americans, the CART model had the highest AUC whereas for African Americans, the LR model with the CART discovered factors had the largest AUC. CONCLUSION AND IMPACT: These results provide new insight into underlying prostate cancer biology for European Americans and African Americans. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21493872      PMCID: PMC3111844          DOI: 10.1158/1055-9965.EPI-10-0996

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  50 in total

1.  Ancestry estimation and correction for population stratification in molecular epidemiologic association studies.

Authors:  Jill S Barnholtz-Sloan; Brian McEvoy; Mark D Shriver; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-03       Impact factor: 4.254

2.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

3.  Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs.

Authors:  B Richards; J Skoletsky; A P Shuber; R Balfour; R C Stern; H L Dorkin; R B Parad; D Witt; K W Klinger
Journal:  Hum Mol Genet       Date:  1993-02       Impact factor: 6.150

Review 4.  Epidemiology of prostate cancer: molecular and environmental clues.

Authors:  K J Pienta; J A Goodson; P S Esper
Journal:  Urology       Date:  1996-11       Impact factor: 2.649

5.  Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.

Authors:  Margaret C Binnie; Freda E Alexander; Charlotte Heald; Fouad K Habib
Journal:  Prostate       Date:  2005-06-01       Impact factor: 4.104

6.  GGN repeat length and GGN/CAG haplotype variations in the androgen receptor gene and prostate cancer risk in south Indian men.

Authors:  Krishnaswamy Vijayalakshmi; Kumarasamy Thangaraj; Singh Rajender; Venkatesan Vettriselvi; Perumal Venkatesan; Sunil Shroff; K N Vishwanathan; Solomon F D Paul
Journal:  J Hum Genet       Date:  2006-09-13       Impact factor: 3.172

7.  5alpha-reductase 2 polymorphisms as risk factors in prostate cancer.

Authors:  Torbjörn Söderström; Mia Wadelius; Swen-Olov Andersson; Jan-Erik Johansson; Sara Johansson; Fredrik Granath; Anders Rane
Journal:  Pharmacogenetics       Date:  2002-06

8.  Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA.

Authors:  Ina Koch; Regina Weil; Renzo Wolbold; Jürgen Brockmöller; Elisabeth Hustert; Oliver Burk; Andreas Nuessler; Peter Neuhaus; Michel Eichelbaum; Ulrich Zanger; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2002-10       Impact factor: 3.922

9.  Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

Authors:  L J Vatten; G Ursin; R K Ross; F Z Stanczyk; R A Lobo; S Harvei; E Jellum
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1997-11       Impact factor: 4.254

10.  Polymorphisms in the androgen receptor and type II 5 alpha-reductase genes and prostate cancer prognosis.

Authors:  Atsuko Shibata; Maria Isabel Garcia; Iona Cheng; Thomas A Stamey; John E McNeal; James D Brooks; Stavonnie Henderson; Cheryl E Yemoto; Donna M Peehl
Journal:  Prostate       Date:  2002-09-01       Impact factor: 4.104

View more
  8 in total

Review 1.  Genetic variation in CYP3A43 is associated with response to antipsychotic medication.

Authors:  Eva J Brandl; Nabilah I Chowdhury; Arun K Tiwari; Tristram A P Lett; Herbert Y Meltzer; James L Kennedy; Daniel J Müller
Journal:  J Neural Transm (Vienna)       Date:  2014-08-24       Impact factor: 3.575

2.  Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Authors:  Jie Li; Emma Mercer; Xin Gou; Yong-Jie Lu
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

3.  Identification of functional modules by integration of multiple data sources using a Bayesian network classifier.

Authors:  Jinlian Wang; Yiming Zuo; Lun Liu; Yangao Man; Mahlet G Tadesse; Habtom W Ressom
Journal:  Circ Cardiovasc Genet       Date:  2014-04

4.  Splitting random forest (SRF) for determining compact sets of genes that distinguish between cancer subtypes.

Authors:  Xiaowei Guan; Mark R Chance; Jill S Barnholtz-Sloan
Journal:  J Clin Bioinforma       Date:  2012-05-22

5.  Prognostic classification index in Iranian colorectal cancer patients: Survival tree analysis.

Authors:  Amal Saki Malehi; Fakher Rahim
Journal:  South Asian J Cancer       Date:  2016 Jan-Mar

6.  Acute Mountain Sickness Symptoms Depend on Normobaric versus Hypobaric Hypoxia.

Authors:  Dana M DiPasquale; Gary E Strangman; N Stuart Harris; Stephen R Muza
Journal:  Biomed Res Int       Date:  2016-10-25       Impact factor: 3.411

7.  PARP-1 Variant Rs1136410 Confers Protection against Coronary Artery Disease in a Chinese Han Population: A Two-Stage Case-Control Study Involving 5643 Subjects.

Authors:  Xue-Bin Wang; Ning-Hua Cui; Shuai Zhang; Shu-Ren Guo; Ze-Jin Liu; Liang Ming
Journal:  Front Physiol       Date:  2017-11-14       Impact factor: 4.566

8.  Comparison of three data mining models for prediction of advanced schistosomiasis prognosis in the Hubei province.

Authors:  Guo Li; Xiaorong Zhou; Jianbing Liu; Yuanqi Chen; Hengtao Zhang; Yanyan Chen; Jianhua Liu; Hongbo Jiang; Junjing Yang; Shaofa Nie
Journal:  PLoS Negl Trop Dis       Date:  2018-02-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.